Emergent BioSolutions Inc
For the period ended May 23, 2024. Filed Apr 11, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 23, 2024 · Filed Apr 11, 2024
EBS$6.06+3.6%Stored close · as of Nov 6, 2026
Contents
Compensation Framework
The following table summarizes the core elements of the executive compensation program in operation during 2023.
| Target Compensation Mix(1) · Key Features in 2023 | |||
|---|---|---|---|
| Pay Component · CEO · Other NEOs | |||
| Base Salary Provide compensation that is competitive. · ✓ Reflects an executive’s role and scope of responsibility, and the experience, time in role, expertise, and future potential of the executive. ✓ Increases consideration of individual performance as well as overall company performance more broadly. ✓ Generally, within a competitive range of the 50th percentile as compared to peer group informed by the factors noted above. | |||
| Annual Cash Incentive Provide performance-based, short- term cash compensation relative to the achievement of pre-set objectives. · ✓ Based on corporate performance for the CEO, and a combination of corporate (90%) and individual (10%) performance for the other participating NEOs. ✓ Payouts can range from 0% – 150% of target. ✓ Bonus targets generally set with reference to the market 50th percentile as well as internal relativities, where appropriate. ✓ Following approval of the KERP, NEOs were not eligible for annual cash incentives in respect of 2023 performance. | |||
| Equity Incentives Provide performance-based, shortterm cash compensation relative to the achievement of pre-set objectives. · ✓ Granted in a combination of PSUs (50%), stock options (25%) and RSUs (25%). ✓ PSUs based on three-year cumulative adjusted EBITDA margin and three-year cumulative total revenues. ✓ Stock options and RSUs typically vest in three equal annual installments over a three-year period. ✓ Stock options subject to a seven-year term. | |||
| Retirement and Health andWelfare Benefits Promote healthiness and financial readiness for retirement. | — | — | ✓ Executives participate in programs on the same basis as other employees. ✓ Benefits include health insurance, life and disability insurance, dental insurance and a 401(k) plan. |
| (1) | Data based on 2023 annual target compensation values for 2023. Other NEOs reflects the average all of the NEOs that had 2023 targets set other than the CEO. Data for the role of CEO reflects Mr. Kramer’s 2023 target compensation approved by the Compensation Committee prior to his retirement. |
46 EMERGENT BIOSOLUTIONS INC. | 2024 Notice and Proxy
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.